WO2008093737A1 - アミド誘導体 - Google Patents
アミド誘導体 Download PDFInfo
- Publication number
- WO2008093737A1 WO2008093737A1 PCT/JP2008/051418 JP2008051418W WO2008093737A1 WO 2008093737 A1 WO2008093737 A1 WO 2008093737A1 JP 2008051418 W JP2008051418 W JP 2008051418W WO 2008093737 A1 WO2008093737 A1 WO 2008093737A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substituted
- hydrogen atom
- alkyl group
- group
- amide derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08704181A EP2119702A4 (en) | 2007-01-31 | 2008-01-30 | amide derivative |
US12/524,921 US20100056497A1 (en) | 2007-01-31 | 2008-01-30 | Amide derivative |
JP2008556153A JPWO2008093737A1 (ja) | 2007-01-31 | 2008-01-30 | アミド誘導体 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007022513 | 2007-01-31 | ||
JP2007-022513 | 2007-01-31 | ||
JP2007050871 | 2007-02-28 | ||
JP2007-050871 | 2007-02-28 | ||
JP2007338384 | 2007-12-27 | ||
JP2007-338384 | 2007-12-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008093737A1 true WO2008093737A1 (ja) | 2008-08-07 |
Family
ID=39674045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/051418 WO2008093737A1 (ja) | 2007-01-31 | 2008-01-30 | アミド誘導体 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20100056497A1 (ja) |
EP (1) | EP2119702A4 (ja) |
JP (1) | JPWO2008093737A1 (ja) |
TW (1) | TW200901999A (ja) |
WO (1) | WO2008093737A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009072649A1 (ja) * | 2007-12-08 | 2009-06-11 | Dainippon Sumitomo Pharma Co., Ltd. | 4-アリールフェニル誘導体 |
WO2009078481A1 (ja) * | 2007-12-19 | 2009-06-25 | Dainippon Sumitomo Pharma Co., Ltd. | 二環性へテロ環誘導体 |
US20100197715A1 (en) * | 2009-01-27 | 2010-08-05 | Sabine Kolczewski | Piperidine derivatives |
WO2010150840A1 (ja) | 2009-06-24 | 2010-12-29 | 大日本住友製薬株式会社 | N-置換-環状アミノ誘導体 |
JP2011157391A (ja) * | 2008-06-19 | 2011-08-18 | Takeda Chem Ind Ltd | 複素環化合物およびその用途 |
US8329691B2 (en) | 2007-10-15 | 2012-12-11 | Takeda Pharmaceutical Company Limited | Amide compounds and use of the same |
US8470816B2 (en) | 2007-12-03 | 2013-06-25 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound and use thereof |
Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992021672A1 (en) | 1991-05-30 | 1992-12-10 | G. D. Searle & Co. | Pla2 inhibitors |
JPH0812605A (ja) | 1994-04-28 | 1996-01-16 | Chisso Corp | 液晶性化合物、液晶組成物および液晶表示素子 |
WO1997018813A1 (en) | 1995-11-22 | 1997-05-29 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5817678A (en) | 1995-11-22 | 1998-10-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1999054321A1 (en) | 1998-04-21 | 1999-10-28 | Aventis Pharma Limited | Substituted diamines and their use as cell adhesion inhibitors |
WO2002002525A2 (en) | 2000-06-30 | 2002-01-10 | Bristol-Myers Squibb Pharma Company | N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
WO2002010172A1 (fr) | 2000-08-01 | 2002-02-07 | Aventis Pharma Sa | Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
WO2004007491A1 (en) | 2002-07-10 | 2004-01-22 | Applied Research Systems Ars Holding N.V. | Azolidinone-vinyl fused-benzene derivatives |
WO2004028467A2 (en) | 2002-09-25 | 2004-04-08 | University Of Wyoming | Diagnosis of bovine viral diarrhea virus |
WO2004096773A1 (en) | 2003-04-25 | 2004-11-11 | Eli Lilly And Company | Quinolone derivatives |
WO2004110955A1 (de) * | 2003-06-12 | 2004-12-23 | Robert Bosch Gmbh | Verfahren zur herstellung eines isolierenden keramik-verbund-werkstoffes und isolierender keramik-verbund-werkstoff |
WO2005028467A1 (en) | 2003-09-15 | 2005-03-31 | Anadys Pharmaceuticals, Inc. | Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds |
WO2005053663A2 (en) * | 2003-11-24 | 2005-06-16 | Eli Lilly And Company | Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
WO2005082872A1 (ja) | 2004-03-02 | 2005-09-09 | Dainippon Sumitomo Pharma Co., Ltd. | ベンゾチアジン-3-オン化合物及びその製造中間体 |
WO2005085275A1 (en) | 2004-02-27 | 2005-09-15 | Schering Corporation | Inhibitors of hepatitis c virus ns3 protease |
WO2005095357A2 (en) | 2004-03-30 | 2005-10-13 | Taisho Pharmaceutical Co., Ltd. | Pyrimidine derivatives and methods of treatment related to the use thereof |
WO2005105780A2 (en) | 2004-04-28 | 2005-11-10 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of rock and other protein kinases |
WO2006039325A2 (en) | 2004-10-01 | 2006-04-13 | Merck & Co., Inc. | Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
WO2006066896A2 (en) | 2004-12-23 | 2006-06-29 | Novartis Ag | Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
WO2006069788A1 (en) | 2004-12-30 | 2006-07-06 | Novartis Ag | Organic compounds |
WO2006094763A1 (en) | 2005-03-09 | 2006-09-14 | Novartis Ag | 3,4,5-substituted piperidine compounds |
WO2006100036A1 (en) | 2005-03-23 | 2006-09-28 | Novartis Ag | 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6849620B2 (en) * | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
EP1442037A1 (en) * | 2001-11-09 | 2004-08-04 | PHARMACIA & UPJOHN COMPANY | Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
US20040204455A1 (en) * | 2003-04-10 | 2004-10-14 | Cody Wayne Livingston | Piperidine derivative rennin inhibitors |
ES2305776T3 (es) * | 2003-06-17 | 2008-11-01 | Pfizer Inc. | Derivados de n-pirrolidin-3-il-amida como inhibidores de la re-captacion de serotonina y noradrenalina. |
CA2708866A1 (en) * | 2007-12-19 | 2009-06-25 | Hiroyuki Nakahira | Bicyclic heterocyclic derivative |
-
2008
- 2008-01-30 EP EP08704181A patent/EP2119702A4/en active Pending
- 2008-01-30 US US12/524,921 patent/US20100056497A1/en not_active Abandoned
- 2008-01-30 JP JP2008556153A patent/JPWO2008093737A1/ja not_active Withdrawn
- 2008-01-30 WO PCT/JP2008/051418 patent/WO2008093737A1/ja active Search and Examination
- 2008-01-31 TW TW097103808A patent/TW200901999A/zh unknown
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992021672A1 (en) | 1991-05-30 | 1992-12-10 | G. D. Searle & Co. | Pla2 inhibitors |
JPH0812605A (ja) | 1994-04-28 | 1996-01-16 | Chisso Corp | 液晶性化合物、液晶組成物および液晶表示素子 |
WO1997018813A1 (en) | 1995-11-22 | 1997-05-29 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5817678A (en) | 1995-11-22 | 1998-10-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1999054321A1 (en) | 1998-04-21 | 1999-10-28 | Aventis Pharma Limited | Substituted diamines and their use as cell adhesion inhibitors |
WO2002002525A2 (en) | 2000-06-30 | 2002-01-10 | Bristol-Myers Squibb Pharma Company | N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
WO2002010172A1 (fr) | 2000-08-01 | 2002-02-07 | Aventis Pharma Sa | Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
WO2004007491A1 (en) | 2002-07-10 | 2004-01-22 | Applied Research Systems Ars Holding N.V. | Azolidinone-vinyl fused-benzene derivatives |
WO2004028467A2 (en) | 2002-09-25 | 2004-04-08 | University Of Wyoming | Diagnosis of bovine viral diarrhea virus |
WO2004096773A1 (en) | 2003-04-25 | 2004-11-11 | Eli Lilly And Company | Quinolone derivatives |
WO2004110955A1 (de) * | 2003-06-12 | 2004-12-23 | Robert Bosch Gmbh | Verfahren zur herstellung eines isolierenden keramik-verbund-werkstoffes und isolierender keramik-verbund-werkstoff |
WO2005028467A1 (en) | 2003-09-15 | 2005-03-31 | Anadys Pharmaceuticals, Inc. | Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds |
WO2005053663A2 (en) * | 2003-11-24 | 2005-06-16 | Eli Lilly And Company | Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
WO2005085275A1 (en) | 2004-02-27 | 2005-09-15 | Schering Corporation | Inhibitors of hepatitis c virus ns3 protease |
WO2005082872A1 (ja) | 2004-03-02 | 2005-09-09 | Dainippon Sumitomo Pharma Co., Ltd. | ベンゾチアジン-3-オン化合物及びその製造中間体 |
WO2005095357A2 (en) | 2004-03-30 | 2005-10-13 | Taisho Pharmaceutical Co., Ltd. | Pyrimidine derivatives and methods of treatment related to the use thereof |
WO2005105780A2 (en) | 2004-04-28 | 2005-11-10 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of rock and other protein kinases |
WO2006039325A2 (en) | 2004-10-01 | 2006-04-13 | Merck & Co., Inc. | Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
WO2006066896A2 (en) | 2004-12-23 | 2006-06-29 | Novartis Ag | Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
WO2006069788A1 (en) | 2004-12-30 | 2006-07-06 | Novartis Ag | Organic compounds |
WO2006094763A1 (en) | 2005-03-09 | 2006-09-14 | Novartis Ag | 3,4,5-substituted piperidine compounds |
WO2006100036A1 (en) | 2005-03-23 | 2006-09-28 | Novartis Ag | 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
Non-Patent Citations (43)
Title |
---|
"Jikken-Kagaku-Koza", vol. 22, MARUZEN |
"Protective Groups in Organic Synthesis", JOHN WILEY & SONS, INC |
"Protective Groups in Organic Synthesis", JOHN WILEY & SONS, INC. |
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 1621, 2006, pages 16 |
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 13, 2005, pages 59 |
CHEM. PHARM. BULL., vol. 40, 1992, pages 102 |
CHEM. PHARM. BULL., vol. 46, 1998, pages 1716 |
CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 46, 1998, pages 1716 |
CIRCULATION, vol. 111, no. 8, 2005, pages 10 12 - 8 |
CURR DIAB REP., vol. 6, no. 1, 2006, pages 8 - 16 |
CURR HYPERTENS REP., vol. 6, no. 2, 2004, pages 129 - 32 |
HYPERTENSION, vol. 42, no. 6, 2003, pages 137 - 43 |
J AM SOC NEPHROL, vol. 16, 2005, pages 592 - 599 |
J EXP MED., vol. 106, no. 3, 1957, pages 439 - 53 |
J HYPERTENS, vol. 23, no. 1, 2005, pages 9 - 17 |
J HYPERTENS, vol. 24, no. 4, 2006, pages 82 |
J. AM. CHEM. SOC., vol. 123, 2001, pages 6989 |
J. CHEM. SOC. PERKIN TRANS, vol. 2, 1988, pages 691 |
J. COMBINATORIAL CHEMISTRY, vol. 8, 2006, pages 469 |
J. MED. CHEM., vol. 26, 1983, pages 507 |
J. OR G. CHEM., vol. 57, 1992, pages 7194 |
J. OR G. CHEM., vol. 61, 1996, pages 6033 |
J. OR G. CHEM., vol. 70, 2005, pages 4360 |
J. OR G. CHEM., vol. 70, 2005, pages 6956 |
J. OR G. CHEM., vol. 71, 2006, pages 6522 |
J. ORG. CHEM., vol. 61, 1996, pages 3849 |
J. ORG. CHEM., vol. 63, 1998, pages 370 |
J. ORG. CHEM., vol. 68, 2003, pages 4120 |
J. ORG. CHEM., vol. 70, 2005, pages 2195 |
NAT REV DRUG DISCOV., vol. 1, no. 8, 2002, pages 621 - 36 |
PHYSIOL. REV., vol. 86, 2006, pages 747 - 803 |
R. C. LAROQUE: "Comprehensive Organic transformation", 1989, VCH PUBLISHER INC |
R. C. LAROQUE: "Comprehensive Organic transformation", 1989, VCH PUBLISHER INC. |
R. C. LAROQUE: "Comprehensive Organic transformation", vol. 61, 1989, VCH PUBLISHER INC., pages: 3849 |
See also references of EP2119702A4 * |
SYNTH. COMMUN., vol. 27, 1997, pages 2943 |
SYNTH. COMMUN., vol. 29, 1999, pages 591 |
SYNTHETIC COMMUNICATIONS, vol. 34, 2004, pages 219 |
TETRAHEDRON LETTERS, vol. 43, 2002, pages 4275 |
TETRAHEDRON LETTERS, vol. 46, 2005, pages 7495 |
TETRAHEDRON: ASYMMETRY, vol. 16, 2005, pages 2599 |
TETRAHEDRON: ASYMMETRY, vol. 17, 2006, pages 993 |
TETRAHEDRON: ASYMMETRY, vol. 8, 1997, pages 3685 |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8329691B2 (en) | 2007-10-15 | 2012-12-11 | Takeda Pharmaceutical Company Limited | Amide compounds and use of the same |
US8470816B2 (en) | 2007-12-03 | 2013-06-25 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound and use thereof |
WO2009072649A1 (ja) * | 2007-12-08 | 2009-06-11 | Dainippon Sumitomo Pharma Co., Ltd. | 4-アリールフェニル誘導体 |
WO2009078481A1 (ja) * | 2007-12-19 | 2009-06-25 | Dainippon Sumitomo Pharma Co., Ltd. | 二環性へテロ環誘導体 |
JP5484069B2 (ja) * | 2007-12-19 | 2014-05-07 | 大日本住友製薬株式会社 | 二環性へテロ環誘導体 |
US20110190278A1 (en) * | 2007-12-19 | 2011-08-04 | Dainippon Sumitomo Pharma Co. | Bicyclic heterocyclic derivative |
US8389511B2 (en) | 2007-12-19 | 2013-03-05 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic heterocyclic derivative |
JP2011157391A (ja) * | 2008-06-19 | 2011-08-18 | Takeda Chem Ind Ltd | 複素環化合物およびその用途 |
US8466282B2 (en) | 2008-06-19 | 2013-06-18 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
US8664380B2 (en) | 2008-06-19 | 2014-03-04 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
US9045436B2 (en) | 2008-06-19 | 2015-06-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
US9221836B2 (en) | 2008-06-19 | 2015-12-29 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
US20100197715A1 (en) * | 2009-01-27 | 2010-08-05 | Sabine Kolczewski | Piperidine derivatives |
US9067911B2 (en) | 2009-01-27 | 2015-06-30 | Hoffmann-La Roche Inc. | Piperidine derivatives |
JPWO2010150840A1 (ja) * | 2009-06-24 | 2012-12-10 | 大日本住友製薬株式会社 | N−置換−環状アミノ誘導体 |
EP2447264A4 (en) * | 2009-06-24 | 2012-12-12 | Dainippon Sumitomo Pharma Co | N-SUBSTITUTED CYCLIC AMINO DERIVATIVE |
EP2447264A1 (en) * | 2009-06-24 | 2012-05-02 | Dainippon Sumitomo Pharma Co., Ltd. | N-substituted-cyclic amino derivative |
WO2010150840A1 (ja) | 2009-06-24 | 2010-12-29 | 大日本住友製薬株式会社 | N-置換-環状アミノ誘導体 |
JP5331883B2 (ja) * | 2009-06-24 | 2013-10-30 | 大日本住友製薬株式会社 | N−置換−環状アミノ誘導体 |
US8658639B2 (en) | 2009-06-24 | 2014-02-25 | Dainippon Sumitomo Pharma Co., Ltd | N-substituted-cyclic amino derivative |
Also Published As
Publication number | Publication date |
---|---|
EP2119702A4 (en) | 2010-12-08 |
US20100056497A1 (en) | 2010-03-04 |
EP2119702A1 (en) | 2009-11-18 |
JPWO2008093737A1 (ja) | 2010-05-20 |
TW200901999A (en) | 2009-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008136457A1 (ja) | 含窒素芳香族誘導体 | |
WO2008093737A1 (ja) | アミド誘導体 | |
WO2009078481A1 (ja) | 二環性へテロ環誘導体 | |
WO2008108378A3 (en) | Bicyclic oxomorpholine derivative | |
WO2009020140A1 (ja) | アダマンチルウレア誘導体 | |
WO2008111473A1 (ja) | グルコキナーゼ活性化物質 | |
WO2008111441A1 (ja) | 医薬組成物 | |
WO2009054479A1 (ja) | スピロ環化合物及びその医薬用途 | |
WO2007009656A3 (de) | Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung | |
MY148703A (en) | Polycyclic cinnamide derivatives | |
WO2005105749A3 (en) | Process for making montelukast and intermediates therefor | |
WO2008120754A1 (ja) | ピコリン酸アミド化合物 | |
WO2007032019A3 (en) | Process for preparing valsartan | |
WO2008146914A1 (ja) | 複素環化合物 | |
WO2007057225A3 (en) | Process for making montelukast and intermediates therefor | |
WO2009020137A1 (ja) | アミノピラゾールアミド誘導体 | |
WO2007099548A3 (en) | Novel 11 beta - hydroxyandrosta-4-ene-3-ones | |
WO2010066629A3 (en) | Novel azaindoles | |
WO2008111632A1 (ja) | 2,2,4-トリメチル-6-フェニル-1,2-ジヒドロキノリン誘導体からなるグルココルチコイド受容体アゴニスト | |
WO2007103508A3 (en) | Ligands for nematode nuclear receptors and uses thereof | |
WO2009005002A1 (ja) | キノロン誘導体 | |
WO2007049729A3 (en) | Amide compounds and their use | |
WO2009014217A1 (ja) | 二環性ピロール誘導体 | |
WO2009063991A1 (ja) | ピリドオキサゼピン誘導体およびその用途 | |
WO2006026034A3 (en) | Processes for the preparation of isothiazole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08704181 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2008556153 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12524921 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008704181 Country of ref document: EP |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) |